Journal of Clinical & Experimental Neuroimmunology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Clin Exp Neuroimmunol 7: 175,

Treatment options for Individuals with Neuromyelitis optica Spectrum disorder people with Neuromyelitis Optica Spectrum disorder suffer Stigma during the COVID-19 Epidemic

Ulrich Kutschera*
Environmental Department, Pario Psychology & Environmental Sciences, Dartmouth, Japan
*Corresponding Author : Ulrich Kutschera, Environmental Department, Pario Psychology & Environmental Sciences, Dartmouth, Japan, Email: KutscheraU@gmail.com

Received Date: Mar 02, 2023 / Published Date: Mar 30, 2023

Citation: Kutschera U (2023) Treatment options for Individuals with Neuromyelitisoptica Spectrum disorder people with Neuromyelitis Optica Spectrum disordersuffer Stigma during the COVID-19 Epidemic. J Clin Exp Neuroimmunol, 8: 175.

Copyright: © 2023 Kutschera U. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top